CompletedNCT00001920
Official study titleInvestigation of Brain Function During Eyeblink Responding in Normal Volunteers and Patients With Schizophrenia (A Study of Behavior and Evoked Potentials)
This study has finished and is no longer accepting participants.
In BethesdaSchizophreniaObservational studyAges 18–60
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH) (Government agency)
CompletedNCT02151656
What is this study about?Researchers compared F17464 and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including NîmesSchizophreniaMedication studyAges 18–64
- Countries
- France, Hungary, Latvia, + 2 others
- Sponsor
- Pierre Fabre Medicament
CompletedNCT00338598
Official study titleFacilitation of NMDA Receptor Function in Patients With Schizophrenia and Co-morbid Alcoholism
This study has finished and is no longer accepting participants.
In West HavenSchizophreniaMedication studyAges 21–60
- Countries
- United States
- Sponsor
- Yale University
CompletedNCT02166918
Official study titleMulticenter Study on Factors Influencing Real-life Social Functioning of People With a Diagnosis of Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including NaplesSchizophreniaObservational studyAges 18–65
- Countries
- Italy
- Sponsor
- University of Campania Luigi Vanvitelli
CompletedNCT00666146
This study has finished and is no longer accepting participants.
Multiple locations, including BaltimorePersonality disorders, SchizophreniaObservational studyAges 16–58
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
CompletedNCT04027634
Official study titleFeasibility and Preliminary Effect of Baduanjin Program for People Diagnosed With Schizophrenia: A Pilot Randomized Controlled Trial
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaInterventional studyAges 20–65
- Countries
- Sponsor
- National Yang Ming Chiao Tung University
CompletedNCT00930150
Official study titleCognitive Remediation in the Schizophrenia Trials Network
This study has finished and is no longer accepting participants.
Multiple locations, including New HavenSchizophreniaBehavioural studyAges 18–55
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH) (Government agency)
CompletedNCT01312649
Official study titleFeeling of Being in Control of One's Own Action: Which Mechanisms in Healthy Volunteers and in Mental Diseases
This study has finished and is no longer accepting participants.
In StrasbourgSchizophrenia, BipolarityBehavioural studyAges 18–55
- Countries
- France
- Sponsor
- University Hospital, Strasbourg, France
CompletedNCT01779700
What is this study about?This study evaluated the safety and effectiveness of Fingolimod for people with schizophrenia.
This study has finished and is no longer accepting participants.
In IndianapolisSchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Indiana University
CompletedNCT00573287
Official study titleClozapine Vs. Risperidone for People With First Episode Schizophrenia and Co-Occurring Substance Use Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including ConcordSchizophrenia, AddictionMedication studyAges 17–45
- Countries
- United States
- Sponsor
- Dartmouth-Hitchcock Medical Center
TerminatedNCT03929497
What is this study about?Researchers are studying Lu AF11167, tracking side effects to assess long-term safety and tolerability in people with schizophrenia.
This study ended early.
Multiple locations, including BurgasSchizophreniaMedication studyAges 18+
- Countries
- Bulgaria, Estonia, Germany, + 4 others
- Sponsor
- H. Lundbeck A/S
CompletedNCT02892422
What is this study about?Researchers studied Lu AF35700, tracking side effects to assess long-term safety and tolerability in adults with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including BellflowerSchizophreniaMedication studyAges 18+
- Countries
- United States, Canada, Bulgaria, + 10 others
- Sponsor
- H. Lundbeck A/S